Safety and efficacy of treating symptomatic, partial-thickness rotator cuff tears with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated at the point of care: a prospective, randomized, controlled first-in-human pilot study.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
30 Mar 2020
Historique:
received: 07 01 2020
accepted: 12 03 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 8 1 2021
Statut: epublish

Résumé

This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection. Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 10 No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05). This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing. Clinicaltrials.gov ID NCT02918136. Registered September 28, 2016, https://clinicaltrials.gov/ct2/show/NCT02918136. Level I; prospective, randomized, controlled trial.

Sections du résumé

BACKGROUND BACKGROUND
This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection.
METHODS METHODS
Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 10
RESULTS RESULTS
No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05).
DISCUSSION CONCLUSIONS
This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing.
TRIAL REGISTRATION BACKGROUND
Clinicaltrials.gov ID NCT02918136. Registered September 28, 2016, https://clinicaltrials.gov/ct2/show/NCT02918136.
LEVEL OF EVIDENCE METHODS
Level I; prospective, randomized, controlled trial.

Identifiants

pubmed: 32238172
doi: 10.1186/s13018-020-01631-8
pii: 10.1186/s13018-020-01631-8
pmc: PMC7110715
doi:

Banques de données

ClinicalTrials.gov
['NCT02918136']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

122

Subventions

Organisme : Sanford Health
ID : N/A
Organisme : InGeneron, Inc.
ID : N/A

Références

Knee Surg Sports Traumatol Arthrosc. 2012 Feb;20(2):373-7
pubmed: 21773831
Am J Sports Med. 2013 Sep;41(9):2041-7
pubmed: 23880402
Adv Orthop. 2015;2015:458786
pubmed: 26171251
Ann Intern Med. 2017 Jul 4;167(1):40-47
pubmed: 28630973
Arthroscopy. 2019 Dec 17;:
pubmed: 31862292
Lancet. 2018 Mar 3;391(10123):883-910
pubmed: 28987452
Cell Transplant. 2015;24(3):509-20
pubmed: 25654771
Gastroenterology. 2009 Mar;136(3):978-89
pubmed: 19135996
Int Orthop. 2014 Sep;38(9):1811-8
pubmed: 24913770
Am J Sports Med. 2014 Feb;42(2):451-6
pubmed: 24318610
Am J Sports Med. 2005 Sep;33(9):1405-17
pubmed: 16127127
J Bone Joint Surg Am. 1995 Jan;77(1):10-5
pubmed: 7822341
Int Orthop. 2013 Nov;37(11):2165-71
pubmed: 23760681
Arthroscopy. 2015 Feb;31(2):306-20
pubmed: 25450417
Biomed Res Int. 2013;2013:383685
pubmed: 24106704
Mol Imaging Biol. 2011 Aug;13(4):633-45
pubmed: 20730500
Clin Orthop Relat Res. 1983 Mar;(173):70-7
pubmed: 6825348
Stem Cells. 2018 Sep;36(9):1441-1450
pubmed: 29790618
Am J Sports Med. 2013 Nov;41(11):2650-7
pubmed: 23942284
Acta Chir Orthop Traumatol Cech. 2015;82(3):229-34
pubmed: 26317295
Biochem Biophys Res Commun. 2007 Nov 23;363(3):674-9
pubmed: 17904522
SAGE Open Med. 2016 Oct 04;4:2050312116671725
pubmed: 27757230
Arthroscopy. 2019 May;35(5):1584-1591
pubmed: 31000394
Eur J Orthop Surg Traumatol. 2019 May;29(4):747-757
pubmed: 30627922
Am J Sports Med. 2017 Jul;45(9):2010-2018
pubmed: 28448728
Mod Rheumatol. 2014 Jul;24(4):667-70
pubmed: 24289196
PLoS One. 2019 Sep 3;14(9):e0221457
pubmed: 31479463
J Shoulder Elbow Surg. 2015 Jun;24(6):860-6
pubmed: 25487905
Health Econ. 1993 Oct;2(3):217-27
pubmed: 8275167
Ann Plast Surg. 2016 Sep;77(3):354-62
pubmed: 27220016
Am J Sports Med. 2019 Mar;47(3):753-761
pubmed: 29466688
J Bone Joint Surg Br. 1964 May;46:314-28
pubmed: 14167640
J Shoulder Elbow Surg. 2019 Mar;28(3):430-436
pubmed: 30651194
Knee Surg Sports Traumatol Arthrosc. 2014 Nov;22(11):2867-73
pubmed: 23736255
J Orthop Surg Res. 2019 Jun 20;14(1):183
pubmed: 31221198
Arthroscopy. 2019 May;35(5):1592-1593
pubmed: 31054733
J Shoulder Elbow Surg. 2015 Dec;24(12):1852-9
pubmed: 26456434
Lancet. 2010 Nov 20;376(9754):1751-67
pubmed: 20970844
J Orthop Res. 2013 Jan;31(1):105-10
pubmed: 22886634
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Orthop J Sports Med. 2016 Mar 31;4(3):2325967116636586
pubmed: 27099865
Clin Rehabil. 2017 Feb;31(2):158-172
pubmed: 26928856
J Shoulder Elbow Surg. 2000 Mar-Apr;9(2):163-8
pubmed: 10810700
Am J Sports Med. 2019 Jul;47(8):1885-1892
pubmed: 31161947
Clin Orthop Relat Res. 1990 May;(254):64-74
pubmed: 2182260
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S174-88
pubmed: 22588743
Semin Cutan Med Surg. 2006 Sep;25(3):138-44
pubmed: 17055393
Muscles Ligaments Tendons J. 2013 Jul 09;3(2):70-9
pubmed: 23888289
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Am J Sports Med. 2009 Sep;37(9):1840-7
pubmed: 19509414
Rev Esp Cir Ortop Traumatol. 2017 Jul - Aug;61(4):249-258
pubmed: 28529030
Int Orthop. 2016 Apr;40(4):759-64
pubmed: 26224616
Am J Sports Med. 1997 May-Jun;25(3):299-305
pubmed: 9167807
Sports Med Arthrosc Rev. 2018 Jun;26(2):59-63
pubmed: 29722764
Orthop J Sports Med. 2018 Nov 16;6(11):2325967118805731
pubmed: 30480012
Injury. 2014 Oct;45 Suppl 4:S22-7
pubmed: 25384471
Plast Reconstr Surg. 1993 Nov;92(6):1085-98; discussion 1099-100
pubmed: 8234507
World J Stem Cells. 2019 Oct 26;11(10):831-858
pubmed: 31692971
Bone Joint J. 2014 Jan;96-B(1):75-81
pubmed: 24395315
World J Orthop. 2014 Nov 18;5(5):623-33
pubmed: 25405091
World J Stem Cells. 2019 Feb 26;11(2):124-146
pubmed: 30842809

Auteurs

Jason L Hurd (JL)

Sanford Orthopedics & Sports Medicine Sioux Falls, 1210 W. 18th St., Suite G01, Sioux Falls, SD, 57104, USA. Jason.Hurd@SanfordHealth.org.

Tiffany R Facile (TR)

Sanford Health, Sioux Falls, SD, USA.

Jennifer Weiss (J)

Sanford Health, Sioux Falls, SD, USA.

Matthew Hayes (M)

Sanford Radiology Clinic, Sioux Falls, SD, USA.

Meredith Hayes (M)

Sanford Radiology Clinic, Sioux Falls, SD, USA.

John P Furia (JP)

SUN Orthopedics of Evangelical Community Hospital, Lewisburg, PA, USA.

Nicola Maffulli (N)

Department of Musculoskeletal Disorders, Faculty of Medicine and Surgery, University of Salerno, Salerno, Italy.
Centre for Sports and Exercise Medicine, Barts and The London School of Medicine and Dentistry, Mile End Hospital, Queen Mary University of London, London, UK.
School of Pharmacy and Bioengineering, Guy Hilton Research Centre, Keele University School of Medicine, Stoke on Trent, UK.

Glenn E Winnier (GE)

InGeneron, Inc., Houston, TX, USA.

Christopher Alt (C)

InGeneron GmbH, Munich, Germany.

Christoph Schmitz (C)

Institute of Anatomy, Faculty of Medicine, LMU Munich, Munich, Germany.

Eckhard U Alt (EU)

Sanford Health, Sioux Falls, SD, USA.
InGeneron, Inc., Houston, TX, USA.
Isar Klinikum, Munich, Germany.

Mark Lundeen (M)

Sanford Orthopedics & Sports Medicine Fargo, Fargo, ND, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH